Every life sciences startup aims to shake up the industry, to go from the lab bench to Wall Street with the backing of all the big-name investors. Unfortunately, it takes much more than just a disruptive scientific idea to get there, which is why so many fledgling companies never make it to the IPO queue, let alone complete a successful stock market debut. What are the keys to success? What does it take to build a biotech startup from scratch, persevere, and convince the public markets to buy into it? And how can you do so even when the macroeconomic environment isn\’t in your favor? 

Join us for a unique event featuring stories from founders and investors of New England biotechs that used very different strategies to pull off some of the biggest recent life sciences IPOs.